Loading

Journal of Cancer Biology and Research

Inhibition of Centrosome Amplification in Human Osteosarcoma Cells (Saos2) by Antioxidants Glutathione and Trolox

Short Communication | Open Access | Volume 3 | Issue 1

  • 1. Department of Biology, University of Southern Indiana, USA
  • 2. Air Force Research Laboratory, USA
+ Show More - Show Less
Corresponding Authors
Richard A. Bennett, Biology Department, 8600 University Blvd., Evansville, IN, USA, Tel: 812-228-5078; Fax: 812-465-1062
ABSTRACT

Mustard gas has been used as a chemical weapon since 1917 during World War  I. Since then, many reports have shown that survivors of attacks and those who make  mustard gas exhibit a higher incidence of cancer than the normal population. We have  recently shown that centrosomes may play a role in mustard gas-induced cancers since  the mustard gas surrogate 2-chloroethyl ethylsulfide (2-CEES) increases centrosome  amplification (more than two centrosomes per cell) in the Saos2 cell line (human   osteosarcoma). To begin to delineate some of the mechanisms that might regulate  2-CEES-induced centrosome amplification, we exposed Saos2 cells to the antioxidants  Trolox and glutathione (GSH) and 2-CEES in various combinations for 24 hours. We  show that Trolox has a minimal effect on inhibiting centrosome amplification, whereas  glutathione prevented 2-CEES-induced centrosome amplification below control levels.  These data provide insight as to how 2-CEES can induce centrosome amplification,  but whether or not that is more related to protein, lipid, or DNA damage is yet to be  determined and should be investigated.

KEYWORDS

  Centrosome amplification;Mustard gas ;2-CEES;Glutathione;Trolox.

CITATION

Bennett RA, Behrens E, Lamkin TJ (2015) Inhibition of Centrosome Amplification in Human Osteosarcoma Cells (Saos2) by Antioxidants Glutathione and Trolox. J Cancer Biol Res 3(1): 1055.

ABBREVIATIONS

MG: Mustard Gas; 2-CEES: 2-chloroethyl ethylsulfide; CIN: Chromosome instability; PCM: Pericentriolar material; MT: Microtubules; GSH: Glutathione; DMEM: Dulbecco’s Modified Eagle’s Medium; Trolox: (±)-6-Hydroxy-2,5,7,8- tetramethylchromane-2-carboxylic acid; PBS: Phosphate buffered saline; TBS: Tris buffered saline; IgG: Immunoglobulin G; DAPI: 4’,6-Diamidino-2-phenylindole; ROS: Reactive oxygen species; PARP: Poly (ADP-Ribose) polymerase; ex: excitation; em: emission

INTRODUCTION

Mustard gas (MG, β, β’-dichloroethyl sulfide) has been used as a chemical weapon since World War I when the Germans attacked British troops in Ypres, Belgium in July 1917, and continues to be a threat today due to its ease of manufacture and use [1,2]. MG is a vesicant (blistering agent) that causes acute damage primarily to the skin, eyes, respiratory, and digestive organs, resulting in a number of complications such as painful blisters on the skin and mucous membranes, respiratory distress, conjunctival irritation, corneal ulceration, nausea, vomiting, and diarrhea [3]. Over time, cancers of various organs can develop in individuals exposed during battle or during the manufacture of MG [4-10]. On a cellular level, MG damages DNA directly by forming monoadducts and interstrand crosslinks with the former being the most common [11,12] and via oxidative stress, forming 8-oxo-2-deoxyguanosine as the major product [13- 15]. Chromosome instability (CIN) is a common phenotype of various cancer types and is thought to introduce multiple genetic lesions required for malignancy through the gain and/or loss of chromosomes during mitosis [16,17]. One mechanism that is thought to drive CIN is centrosome amplification. Centrosomes are small, non-membrane-bound organelles that are composed of two, orthogonally-arranged centrioles surrounded by an amorphous protein matrix called the pericentriolar material (PCM) [18]. They function to organize the microtubule (MT) network, the most notable being the bipolar mitotic spindle during mitosis, which directs the equal segregation of chromosomes during anaphase. After mitosis, daughter cells must duplicate their single centrosomes during S phase of the cell cycle to ensure that two and only two centrosomes are present during the next mitosis [19]. If centrosome duplication is perturbed, centrosomes can fail to duplicate, resulting in a monopolar spindle. Alternatively, centrosomes could duplicate uncontrollably and produce a multipolar spindle, which has been shown to increase the instance of merotely (a single kinetochore attached to microtubules from opposite poles), thereby increasing the instance of lagging chromosome formation and chromosome instability [20]. Centrosome amplification can occur under a number of conditions. For example, inactivating mutations of p53 [21] or p21Waf1 [22] or activating mutations of cyclin E [23] can cause centrosome amplification. Additionally, DNA damage and oxidative stress have been shown to induce centrosome amplification as well [24,25]. We recently showed that 2-chloroethyl ethylsulfide (2-CEES), a surrogate of MG, induces centrosome amplification in Saos2 cells [26]. Since 2-CEES damages DNA and induces oxidative stress [13,14], we wanted to further delineate the mechanisms that drive centrosome amplification in 2-CEES-treated cells using two different antioxidants that affect MG toxicity via two distinct mechanisms. Trolox, a water-soluble analog of Vitamin E [27], is known to inhibit oxidative stress, while glutathione (GSH) forms conjugates with MG directly and prevents both DNA damage and oxidative stress [14]. As a result, we show that Trolox does not significantly reduce 2-CEES-induced centrosome amplification in Saos2 cells, whereas GSH significantly reduces 2-CEESindcued centrosome amplification to levels below that of control conditions.

MATERIALS AND METHODS

Cell Culture

Saos2 cells (human osteosarcoma) were obtained from the American Type Culture Collection (ATCC, Manassa, VA, HTB-85) and cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS, Atlanta Biologicals, Norcross, GA), 100 U/ml penicillin, and 100 μg/ml streptomycin (Hyclone/Fisher, Waltham, MA) for maintenance and experiments. Cells were incubated at 37° C and 10% CO¬2 in a humidified incubator for all experiments.

Cell Treatment

Saos2 cells were plated in 24-well plates containing glass coverslips and incubated overnight so that they were sub confluent after an overnight incubation. Cells were incubated in various combinations of 250 μM 2-chloroethyl ethylsulfide (2-CEES, Sigma, St. Louis, MO), 10 mM glutathione (GSH, Sigma, St. Louis, MO), and 800 μM Trolox (Sigma, St. Louis, MO) for 24 hours and then assayed for centrosomes using indirect immunofluorescent staining.

Centrosome Detection Assay

Cells were grown and treated on glass coverslips as described. After treatment, cells were washed in PBS and fixed in 4% formalin/methanol (FormaldeF resh, Fisher, Waltham, MA) for 20 minutes at room temperature followed by permeabilization with 1% Nonidet P-40 (Fisher, Waltham, MA) in PBS for 10 minutes at room temperature. Cells were blocked in 15% normal goat serum (Life Technologies, Carlsbad, CA) for 1 hour in a humidified chamber and then gently washed by dipping coverslips into three separate beakers of PBS. Cells were then incubated in rabbit-anti-γ tubulin antibody (Cell Signaling, Boston, MA) diluted in PBS for 45 minutes at room temperature. Cells were then washed with PBS for 15 minutes on a rocker and then exposed to AlexaFluor 594-conjugated goat-anti-rabbit IgG antibody (Life Technologies, Carlsbad, CA) diluted in PBS for 45 minutes at room temperature in the dark. Cells were washed in Tris buffered saline (TBS – 150 mM NaCl, 20 mM Tris, pH 7.4) for 15 minutes on a rocker in the dark followed by nuclear counterstaining with 500 nM 4’,6-Diamidino-2-phenylindole (DAPI, Sigma, St. Louis, MO) for 10 minutes in the dark at room temperature. Lastly, coverslips were washed again in TBS for 10 minutes on a rocker in the dark at room temperature and then mounted on coverslips using Fluoromount-G (Southern Biotech, Birmingham, AL). The number of centrosomes was determined for at least 100 cells in each condition.

Centriole Analysis

To identify centrioles, cells were incubated on coverslips and treated as noted above. After treatment, the 24-well plates containing cells were incubated on wet ice for 30 minutes. Coverslips were then transferred to wells containing cold PBS and washed one time with cold PBS. Coverslips were then incubated in cold extraction buffer (0.75% Triton X-100, 5 mM PIPES buffer, 2 mM EGTA) on wet ice for about 10-30 seconds per well. Coverslips were then washed 2-3 times with cold PBS and then incubated in cold fixative (4% formalin/methanol, FormaldeFresh, Fisher, and Waltham, MA) on wet ice for 10 minutes followed by 10 minutes in new, room temperature fixative. Coverslips were gently washed 2-3 times in room temperature PBS and then blocked in 15% normal goat serum (Life Technologies, Carlsbad, CA) for 1 hour in a humidified chamber, followed by a gentle wash in PBS by dipping coverslips into three separate beakers of PBS. Cells were then incubated in rabbit-anti-γ tubulin and mouse-anti-α tubulin antibodies (Cell Signaling, Boston, MA) diluted in PBS for 45 minutes at room temperature. Cells were then washed with PBS for 15 minutes on a rocker and then exposed to Alexa-Fluor 594-conjugated goatanti-rabbit IgG and Alexa-Fluor 488-conjugated goat-anti-mouse IgG antibodies (Life Technologies, Carlsbad, CA) diluted in PBS for 45 minutes at room temperature in the dark. Cells were then washed in Tris buffered saline (TBS – 150 mM NaCl, 20 mM Tris, pH 7.4) for 15 minutes on a rocker in the dark followed by nuclear counterstaining with 500 nM 4’,6-Diamidino-2-phenylindole (DAPI, Sigma, St. Louis, MO) for 10 minutes in the dark at room temperature. Lastly, coverslips were washed again in TBS for 10 minutes on a rocker in the dark at room temperature and then mounted on coverslips using Fluoromount-G (Southern Biotech, Birmingham, AL).

Fluorescent Microscopy

Images were analyzed on a Zeiss AxioImager.A2 fluorescence microscope using 470/40 nm (ex) and 525/50 (em) for γ-tubulin (green), 565/30 (ex) and 620/60 (em) for α-tubulin (red), and 365+ nm (ex) and 445/50 (em) for DAPI (blue). Images were captured using an AxioCam MRm camera and AxioVision software (ver. 4.8.0.0). Figures were assembled using PowerPoint and Adobe Photoshop CS2 (ver. 9.0).

RESULTS AND DISCUSSION

amplification. We previously showed that 2-CEES can induce centrosome amplification in Saos2 cells after 24 hour incubation [26]. Additionally, previous work has shown that GSH and Trolox differentially prevent 2-CEES-induced DNA damage in JB6 cells (mouse skin epidermal cells) and dermal fibroblasts, with GSH being more effective [14]. To further determine how 2-CEES- induced centrosome amplification might occur, we treated Saos2 cells with 250 μM 2-CEES in the presence or absence of 800 μM Trolox, 10 mM GSH, both, or neither, along with the same 2-CEES untreated conditions, for 24 hours. Cells were then immunostained for γ-tubulin (a component of the PCM), to detect centrosomes, and counterstained with DAPI to detect nuclei. Centrosomes appeared as bright green dots (Figure 1A),

Representation of micrographs from which data for

Figure 1 (A) Representation of micrographs from which data for

the number of which was recorded as one, two, or more than two centrosomes per cell for at least 100 cells in each condition and then graphed (Figure 1B).

 was derived. Cells were treated and then immunostained for ?-tubulin  (green) and costained with DAPI (blue). Cells were categorized as having one (1 centrosome), 2 (2 centrosomes), or more than two centrosomes  (>2 centrosomes). (B) The percent of cells in each condition with centrosome amplification (>2 centrosomes). *p < 0.05 compared to cells treated  with 2-CEES only (column 5).

Figure 1B was derived. Cells were treated and then immunostained for γ-tubulin (green) and costained with DAPI (blue). Cells were categorized as having one (1 centrosome), 2 (2 centrosomes), or more than two centrosomes (>2 centrosomes). (B) The percent of cells in each condition with centrosome amplification (>2 centrosomes). *p < 0.05 compared to cells treated with 2-CEES only (column 5).

Untreated, GSH- or Trolox-treated, and cells treated with both antioxidants showed low levels of centrosome amplification (6.2 – 11.4%). 2-CEES-treated cells exhibited high levels of centrosome amplification (24.3%), as expected. Interestingly, co-treatment of cells with 2-CEES and GSH significantly (p < 0.05) decreased centrosome amplification to less than control levels, while co-treatment of cells with 2-CEES and Trolox did not significantly decrease centrosome amplification (p > 0.05). Additionally, co-treatment of cells with 2-CEES, GSH, and Trolox together resulted in a significant decrease in centrosome amplification compared to 2-CEES only-treated cells (8.5% vs. 24.3%). These results indicate that GSH alone or GSH with Trolox is more effective in preventing centrosome amplification than Trolox alone. To ensure that γ-tubulin stained structures were indeed centrosomes, coverslips from untreated and 2-CEEStreated cells were immunostained for both γ- and α-tubulin. γ-tubulin is a major component of the PCM, while α-tubulin is found in both microtubules and centrioles. To specifically identify centrioles, cells were cold-treated, fixed, and immunostained with antibodies against α- and γ-tubulin (Figure 2).

2 ?-tubulin spots are centrosomes. Cells were treated and then immunostained for ?-tubulin (green, PCM), ?-tubulin (red, centrioles), and  counterstained with DAPI (blue). Centrosomes contain centrioles

Figure 2 γ-tubulin spots are centrosomes. Cells were treated and then immunostained for γ-tubulin (green, PCM), α-tubulin (red, centrioles), and counterstained with DAPI (blue). Centrosomes contain centrioles.

As shown, γ- and α-tubulin staining colocalized, indicating that the γ-tubulin staining used to determine centrosome amplification was indeed centrosomes.

CONCLUSION

Here, we have shown that GSH significantly inhibits 2-CEESinduced centrosome amplification in Saos2 cells, whereas Trolox does not. This differential effect on centrosome amplification provides some insight as to how 2-CEES can induce centrosome amplification in these cells. Both MG and 2-CEES form sulfonium ions in the body, which, due to its electrophilic nature, can bind to DNA, RNA, and proteins and cause cell toxicity and death [28- 31]. Additionally, both MG and 2-CEES can lead to an increase in reactive oxygen species (ROS) through the depletion of cellular GSH and antioxidant enzymes like superoxide dismutase, catalase, and glutathione peroxidase [14,32-34]. Interestingly, both DNA damage and oxidative stress have been shown to induce centrosome amplification [24,25]. In this work, we wanted to investigate whether direct macromolecular damage or oxidative stress was responsible for the observed 2-CEESindcued centrosome amplification from out previous work. To do this, we co-treated Saos2 cells with different combinations of GSH, Trolox, and 2-CEES. GSH is known to bind MG directly, forming conjugates, and has been shown to decrease 2-CEESinduced cell death and DNA damage [14,35,36]. Trolox is known to decrease ROS and oxidative DNA damage in cells, but not direct DNA damage by 2-CEES [14]. Thus, any decrease in centrosome amplification due to GSH treatment can be attributed to its ability to prevent both direct macromolecule damage and oxidative stress, while any reduction in centrosome amplification in Trolox-treated cells can be attributed to its ability to prevent only oxidative stress. Our data showed that both GSH and Trolox, individually, decreased 2-CEES-induced centrosome amplification, although the latter was statistically insignificant. Additionally, GSH and Trolox together significantly decreased 2-CEES-induced centrosome amplification in Saos2 cells. This indicates that 2-CEES-induced centrosome amplification likely occurs primarily due to its ability to directly interact with macromolecules. This supports observations that show that many proteins that regulate centrosome duplication are targets of MG toxicity, including p53, poly (ADP-ribose) polymerase (PARP), and NF-κB [21,37-40]. Although we show that GSH treatment significantly prevents 2-CEES-induced centrosome amplification, whether or not that is more related to protein, lipid, or DNA damage is yet to be determined and should be investigated. Lastly, it is possible that the effects seen in our experiments may be the result of perturbations in cell cycle progression. Centrosome duplication is tightly coupled to DNA synthesis during S phase [41,42]. Thus, it is reasonable to think that cell cycle arrest in G1 or S phase would concomitantly prevent centrosome amplification. However, it has been shown that centrosome duplication can still occur during G1 and S phase arrest [17,43]. Trolox has been shown to not induce G1 arrest [44]. Regardless, the effects of GSH and Trolox on cell cycle progression should be investigated in relation to centrosome duplication and amplification.

ACKNOWLEDGEMENTS

The authors would like to thank the Endeavor! Awards Committee, Summer Research Fellowship Committee, the STEMEarly Undergraduate Research Program, and the Pott College Science, Engineering, and Education Research Grant Awards (SEERGA) Committee for financial support.

REFERENCES

1. Duchovic RJ, Vilensky JA. Mustard gas: its pre-World War I history. J Chem Educ. 2007; 84: 944-948.

2. Wattana M, Bey T. Mustard gas or sulfur mustard: an old chemical agent as a new terrorist threat. Prehosp Disaster Med. 2009; 24: 19- 29.

3. Aasted A, Darre E, Wulf HC. Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience. Ann Plast Surg. 1987; 19: 330-333.

4. Doi M, Hattori N, Yokoyama A, Onari Y, Kanehara M, Masuda K, et al. Effect of mustard gas exposure on incidence of lung cancer: a longitudinal study. Am J Epidemiol. 2011; 173: 659-666.

5. Iravani S, Rahnavardi M, Gorouhi F, Gorouhi F. Repeated gastrointestinal malignancies in a victim of sulfur mustard gas attack. Indian J Gastroenterol. 2007; 26: 102.

6. Zojaji R, Balali-Mood M, Mirzadeh M, Saffari A, Maleki M. Delayed head and neck complications of sulphur mustard poisoning in Iranian veterans. J Laryngol Otol. 2009; 123: 1150-1154.

7. Easton DF, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med. 1988; 45: 652-659.

8. Nishimoto Y, Yamakido M, Shigenobu T, Onari K, Yukutake M. Longterm observation of poison gas workers with special reference to respiratory cancers. J UOEH. 1983; 5 Suppl: 89-94.

9. Takeshima Y, Inai K, Bennett WP, Metcalf RA, Welsh JA, Yonehara S, et al. p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis. 1994; 15: 2075-2079.

10. Yamakido M, Ishioka S, Hiyama K, Maeda A. Former poison gas workers and cancer: incidence and inhibition of tumor formation by treatment with biological response modifier N-CWS. Environ Health Perspect. 1996; 104 Suppl 3: 485-488.

11. Wheeler GP. Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res. 1962; 22: 651-688.

12. Fidder A, Moes GW, Scheffer AG, van der Schans GP, Baan RA, de Jong LP, et al. Synthesis, characterization, and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood. Chem Res Toxicol. 1994; 7: 199-204.

13. Pal A, Tewari-Singh N, Gu M, Agarwal C, Huang J, Day BJ, et al. Sulfur mustard analog induces oxidative stress and activates signaling cascades in the skin of SKH-1 hairless mice. Free Radic Biol Med. 2009; 47: 1640-1651.

14. Inturi S, Tewari-Singh N, Gu M, Shrotriya S, Gomez J, Agarwal C, et al. Mechanisms of sulfur mustard analog 2-chloroethyl ethyl sulfideinduced DNA damage in skin epidermal cells and fibroblasts. Free Radic Biol Med. 2011; 51: 2272-2280.

15. Jain AK, Tewari-Singh N, Gu M, Inturi S, White CW, Agarwal R. Sulfur mustard analog, 2-chloroethyl ethyl sulfide-induced skin injury involves DNA damage and induction of inflammatory mediators, in part via oxidative stress, in SKH-1 hairless mouse skin. Toxicol. Lett. 2011; 205: 293-301.

16. Pihan GA, Purohit A, Wallace J, Knecht H, Woda B, Quesenberry P, et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 1998; 58: 3974-3985.

17. Bennett RA, Izumi H, Fukasawa K. Induction of centrosome amplification and chromosome instability in p53-null cells by transient exposure to subtoxic levels of S-phase-targeting anticancer drugs. Oncogene. 2004; 23: 6823-6829.

18. Nigg EA, Raff JW. Centrioles, centrosomes, and cilia in health and disease. Cell. 2009; 139: 663-678.

19. Fukasawa K. Centrosome amplification, chromosome instability and cancer development. Cancer Lett. 2005; 230: 6-19.

20. Ganem NJ, Godinho SA, Pellman D. A mechanism linking extra centrosomes to chromosomal instability. Nature. 2009; 460: 278-282.

21. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF. Abnormal centrosome amplification in the absence of p53. Science. 1996; 271: 1744-1747.

22. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene. 2001; 20: 3173-3184.

23. Kawamura K, Izumi H, Ma Z, Ikeda R, Moriyama M, Tanaka T, et al. Induction of centrosome amplification and chromosome instability in human bladder cancer cells by p53 mutation and cyclin E over expression. Cancer Res. 2004; 64: 4800-4809.

24. Dodson H, Bourke E, Jeffers LJ, Vagnarelli P, Sonoda E, Takeda S, et al. Centrosome amplification induced by DNA damage occurs during a prolonged G2 phase and involves ATM. EMBO J. 2004; 23: 3864-3873.

25. Chae S, Yun C, Um H, Lee JH, Cho H. Centrosome amplification and multinuclear phenotypes are Induced by hydrogen peroxide. Exp Mol Med. 2005; 37: 482-487.

26. Bennett RA, Behrens E, Zinn A, Duncheon C, Lamkin TJ. Mustard gas surrogate, 2-chloroethyl ethylsulfide (2-CEES), induces centrosome amplification and aneuploidy in human and mouse cells : 2-CEES induces centrosome amplification and chromosome instability. Cell Biol Toxicol. 2014; 30: 195-205.

27. Kumar O, Sugendran K, Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem Biol Interact. 2001; 134: 1-12.

28. Wang QQ, Begum RA, Day VW, Bowman-James K. Sulfur, oxygen, and nitrogen mustards: stability and reactivity. Org Biomol Chem. 2012; 10: 8786-8793.

29. Ray R, Hauck S, Kramer R, Benton B. A convenient fluorometric method to study sulfur mustard-induced apoptosis in human epidermal keratinocytes monolayer microplate culture. Drug Chem Toxicol. 2005; 28: 105-116.

30. Bhattacharya R, Rao PV, Pant SC, Kumar P, Tulsawani RK, Pathak U, et Central Bennett et  al. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and in vivo. Toxicol Appl Pharmacol. 2001; 176: 24- 33.

31.Tewari-Singh N, Rana S, Gu M, Pal A, Orlicky DJ, White CW, et al. Inflammatory biomarkers of sulfur mustard analog 2-chloroethyl ethyl sulfide-induced skin injury in SKH-1 hairless mice. Toxicol Sci. 2009; 108: 194-206.

32. Husain K, Dube SN, Sugendran K, Singh R, Das Gupta S, Somani SM. Effect of topically applied sulphur mustard on antioxidant enzymes in blood cells and body tissues of rats. J Appl Toxicol. 1996; 16: 245-248.

33. Paromov V, Suntres Z, Smith M, Stone WL. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J Burns Wounds. 2007; 7: e7.

34. Gould NS, White CW, Day BJ. A role for mitochondrial oxidative stress in sulfur mustard analog 2-chloroethyl ethyl sulfide-induced lung cell injury and antioxidant protection. J Pharmacol Exp Ther. 2009; 328: 732-739.

35. Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol. 2002; 184: 116-126.

36. Han S, Espinoza LA, Liao H, Boulares AH, Smulson ME. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analog 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br J Pharmacol. 2004; 141: 795-802.

37. Bhat KR, Benton BJ, Rosenthal DS, Smulson ME, Ray R. Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur mustard-exposed normal human epidermal keratinocytes (NHEK). J. Appl. Toxicol. 2000; 20: S13-S17.

38. Liu JL, Ma HP, Lu XL, Sun SH, Guo X, Li FC. NF-κB induces abnormal centrosome amplification by upregulation of CDK2 in laryngeal squamous cell cancer. Int J Oncol. 2011; 39: 915-924.

39. Ruff AL, Dillman JF. Sulfur mustard induced cytokine production and cell death: investigating the potential roles of the p38, p53, and NFkappaB signaling pathways with RNA interference. J Biochem Mol Toxicol. 2010; 24: 155-164.

40. Tong WM, Yang YG, Cao WH, Galendo D, Frappart L, Shen Y, et al. Poly (ADP-ribose) polymerase-1 plays a role in suppressing mammary tumourigenesis in mice. Oncogene. 2007; 26: 3857-3867.

41. Mussman JG, Horn HF, Carroll PE, Okuda M, Tarapore P, Donehower LA, et al. Synergistic induction of centrosome hyperamplification by loss of p53 and cyclin E overexpression. Oncogene. 2000; 19: 1635- 1646.

42. Tarapore P, Horn HF, Tokuyama Y, Fukasawa K. Direct regulation of the centrosome duplication cycle by the p53-p21Waf1/Cip1 pathway. Oncogene. 2001; 20: 3173-3184.

43. Durcan TM, Halpin ES, Casaletti L, Vaughan KT, Pierson MR, Woods S, et al. Centrosome duplication proceeds during mimosine-induced G1 cell cycle arrest. J Cell Physiol. 2008; 215: 182-191.

44. Liu M, Wikonkal NM, Brash DE. Induction of cyclin-dependent kinase inhibitors and G (1) prolongation by the chemopreventive agent N-acetylcysteine. Carcinogenesis. 1999; 20: 1869-1872

 

Bennett RA, Behrens E, Lamkin TJ (2015) Inhibition of Centrosome Amplification in Human Osteosarcoma Cells (Saos2) by Antioxidants Glutathione and Trolox. J Cancer Biol Res 3(1): 1055.

Received : 01 Jan 2015
Accepted : 21 Jan 2015
Published : 23 Jan 2015
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Journal of Clinical Nephrology and Research
ISSN : 2379-0652
Launched : 2014
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X